Leonteq Securities’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.51M Sell
126,287
-31,239
-20% -$1.45M 0.23% 83
2026
Q2
$6.72M Buy
157,526
+58,271
+59% +$3.16M 0.23% 78
2026
Q1
$6.23M Buy
99,255
+80,333
+425% +$6.43M 0.23% 83
2025
Q4
$1.8M Buy
18,922
+957
+5% +$93.8K 0.06% 235
2025
Q3
$1.75M Buy
17,965
+2,581
+17% +$267K 0.05% 218
2025
Q2
$1.65M Sell
15,384
-3,045
-17% -$308K 0.06% 183
2025
Q1
$1.85M Sell
18,429
-84
-0.5% -$8.46K 0.1% 167
2024
Q4
$1.65M Sell
18,513
-3,592
-16% -$316K 0.11% 173
2024
Q3
$1.85M Sell
22,105
-3,376
-13% -$266K 0.14% 138
2024
Q2
$1.96M Sell
25,481
-1,948
-7% -$143K 0.14% 136
2024
Q1
$1.88M Sell
27,429
-141
-0.5% -$9.07K 0.14% 163
2023
Q4
$1.59M Sell
27,570
-15,673
-36% -$837K 0.09% 193
2023
Q3
$2.28M Sell
43,243
-4,825
-10% -$253K 0.13% 162
2023
Q2
$2.6M Buy
48,068
+2,765
+6% +$144K 0.13% 164
2023
Q1
$2.27M Sell
45,303
-9,401
-17% -$443K 0.1% 175
2022
Q4
$2.53M Buy
54,704
+7,170
+15% +$310K 0.09% 161
2022
Q3
$1.84M Sell
47,534
-16,973
-26% -$681K 0.07% 191
2022
Q2
$2.4M Buy
64,507
+7,175
+13% +$292K 0.09% 178
2022
Q1
$2.54M Sell
57,332
-46,268
-45% -$2.01M 0.09% 171
2021
Q4
$4.4M Buy
103,600
+31,403
+43% +$1.32M 0.16% 123
2021
Q3
$3.13M Buy
72,197
+14,441
+25% +$639K 0.13% 134
2021
Q2
$2.47M Buy
57,756
+13,507
+31% +$568K 0.15% 127
2021
Q1
$1.71M Sell
44,249
-135
-0.3% -$5.11K 0.1% 174
2020
Q4
$1.6M Buy
+44,384
New +$1.6M 0.09% 194

Other funds holding BSX

Leonteq Securities's BSX Position: Q3 2026 in Review

Leonteq Securities reduced its Boston Scientific (BSX) stake by 20% in Q3 2026, selling an estimated $1.45M and leaving 126,287 shares worth $5.51M. The position accounts for 0.23% of the portfolio, ranked #83.

Leonteq Securities first reported a position in BSX in Q4 2020 and has held it in 24 quarters since. The position peaked at $6.72M in Q2 2026. 1,274 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Leonteq Securities held 126,287 shares of Boston Scientific worth $5.51M as of Q3 2026.
  • Leonteq Securities sold 31,239 Boston Scientific shares in Q3 2026, an estimated $1.45M.
  • Boston Scientific made up 0.23% of Leonteq Securities's portfolio in Q3 2026, its #83 holding.
  • Leonteq Securities first reported a position in Boston Scientific in Q4 2020 and has held it in 24 quarters since.
  • Leonteq Securities's Boston Scientific position peaked at $6.72M in Q2 2026.
  • 1,274 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.